FERTILITY-SPARING TREATMENT OF STAGE 1 ENDOMETRIAL CANCER AND COMPLEX ATYPICAL HYPERPLASIA: PREDICTIVE FACTORS FOR REGRESSION AND REPRODUCTIVE OUTCOMES.

被引:0
|
作者
Chuong, F. S. [1 ]
Yates, M. M. [2 ]
Wu, J. [1 ]
Garcia, J. [1 ]
Kolp, L. [1 ]
Christianson, M. S. [1 ]
机构
[1] Johns Hopkins Univ Hosp, Dept Gynecol & Obstet, Lutherville Timonium, MD USA
[2] Adv Reprod Specialists Orlando, Winter Pk, FL USA
关键词
D O I
10.1016/j.fertnstert.2014.07.552
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
P-67
引用
收藏
页码:E161 / E161
页数:1
相关论文
共 50 条
  • [1] Analysis of assisted reproductive outcomes in patients with atypical endometrial hyperplasia and early-stage endometrial cancer after fertility-sparing treatment
    Li, Jiaheng
    Li, Mengnuo
    Li, Yijiang
    Zhao, Xianling
    Guan, Yichun
    Yuan, Xiaoqiong
    Du, Shanshan
    Zhang, Caihua
    Liu, Wenxia
    Ren, Bingnan
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024,
  • [2] Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
    Chen, Junyu
    Cao, Dongyan
    Yang, Jiaxin
    Yu, Mei
    Zhou, Huimei
    Cheng, Ninghai
    Wang, Jinhui
    Zhang, Ying
    Peng, Peng
    Shen, Keng
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Fertility-sparing management of endometrial cancer and atypical hyperplasia
    Gonthier, C.
    Trefoux-Bourdet, A.
    Luton, D.
    Koskas, M.
    [J]. GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2017, 45 (02): : 112 - 118
  • [4] PROGNOSTIC FACTORS OF ONCOLOGIC AND REPRODUCTIVE OUTCOMES IN FERTILITY-SPARING TREATMENT OF COMPLEX ATYPICAL HYPERPLASIA AND LOW GRADE ENDOMETRIAL CANCER USING ORAL PROGESTIN IN CHINESE PEOPLE
    Zhou, R.
    Lu, Q.
    Wang, J.
    Wang, S.
    Zhu, H.
    Wang, Z.
    Miao, Y.
    Wei, L.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1361 - 1362
  • [5] THE RISK FACTORS AND THERAPEUTIC REGIMENS ANALYSES IN THE FERTILITY-SPARING TREATMENT OF REFRACTORY ENDOMETRIAL ATYPICAL HYPERPLASIA AND ENDOMETRIAL CANCER
    Yang, B.
    Zhou, S.
    Chen, X.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A381 - A381
  • [6] Criteria for resumption of assisted reproductive technology intervention after fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer
    Huttler, Alexandra G.
    Kahn, Jenna L.
    Shah, Divya K.
    Ko, Emily M.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (02) : 393 - 394
  • [7] Criteria for resumption of assisted reproductive technology intervention after fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer
    Huttler, Alexandra
    Kahn, Jenna
    Shah, Divya
    Ko, Emily
    [J]. GYNECOLOGIC ONCOLOGY, 2021, 162 : S122 - S122
  • [8] Fertility-Sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer: A Cochrane Systematic Review Protocol
    Maria-Eulalia Fernandez-Montoli
    Jordi Sabadell
    Nayanar-Adela Contreras-Perez
    [J]. Advances in Therapy, 2021, 38 : 2717 - 2731
  • [9] Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients
    Zhou Rong
    Yang Yuan
    Lu Qun
    Wang Jianliu
    Miao Yali
    Wang Shijun
    Wang Zhiqi
    Zhao Chao
    Wei Lihui
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 139 (03) : 424 - 428
  • [10] Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential
    Pronin, Stanislav Mikhailovich
    Novikova, Olga Valerievna
    Andreeva, Julia Yurievna
    Novikova, Elena Grigorievna
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (06) : 1010 - 1014